Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

MH Abdul-Aziz, JWC Alffenaar, M Bassetti… - Intensive care …, 2020 - Springer
Abstract Purpose This Position Paper aims to review and discuss the available data on
therapeutic drug monitoring (TDM) of antibacterials, antifungals and antivirals in critically ill …

Therapeutic drug monitoring of antibiotics: defining the therapeutic range

MH Abdul–Aziz, K Brady, MO Cotta… - Therapeutic drug …, 2022 - journals.lww.com
Purpose: In the present narrative review, the authors aimed to discuss the relationship
between the pharmacokinetic/pharmacodynamic (PK/PD) of antibiotics and clinical …

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections

A Gonzalez-Ruiz, RA Seaton… - Infection and drug …, 2016 - Taylor & Francis
Infections caused by Gram-positive pathogens remain a major public health burden and are
associated with high morbidity and mortality. Increasing rates of infection with Gram-positive …

Clinical pharmacokinetics of daptomycin

N Gregoire, A Chauzy, J Buyck, B Rammaert… - Clinical …, 2021 - Springer
Due to the low level of resistance observed with daptomycin, this antibiotic has an important
place in the treatment of severe Gram-positive infections. It is the first-in-class of the group of …

Population pharmacokinetics of daptomycin in critically ill patients with various degrees of renal impairment

N Grégoire, S Marchand, M Ferrandière… - Journal of …, 2019 - academic.oup.com
Objectives The objective of this study was to characterize the pharmacokinetics of unbound
and total concentrations of daptomycin in infected ICU patients with various degrees of renal …

Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution

A Galar, P Muñoz, M Valerio, E Cercenado… - International journal of …, 2019 - Elsevier
Therapeutic drug monitoring (TDM) could optimise daptomycin use. However, no validated
serum target levels have been established. This prospective study at a tertiary centre …

The impact of daptomycin therapeutic drug monitoring on clinical outcomes: a systematic review

KA Cairns, IJ Abbott, MJ Dooley, AY Peleg… - International Journal of …, 2023 - Elsevier
Aim Daptomycin therapeutic drug monitoring (TDM) is a potentially valuable intervention for
a relatively new drug. The aim of this study was to determine whether daptomycin TDM …

Pharmacokinetics of non-β-lactam β-lactamase inhibitors

G Luci, F Mattioli, M Falcone, A Di Paolo - Antibiotics, 2021 - mdpi.com
The growing emergence of drug-resistant bacterial strains is an issue to treat severe
infections, and many efforts have identified new pharmacological agents. The inhibitors of β …

Population pharmacokinetics of daptomycin in critically ill patients

A Soraluce, E Asín-Prieto, A Rodríguez-Gascón… - International journal of …, 2018 - Elsevier
Daptomycin has shown activity against a wide range of Gram-positive bacteria; however, the
approved dosages usually seem insufficient for critically ill patients. The aim of this study …

Daptomycin population pharmacokinetics in patients affected by severe gram-positive infections: an update

G Balice, C Passino, MG Bongiorni, L Segreti, A Russo… - Antibiotics, 2022 - mdpi.com
Daptomycin pharmacokinetics may not depend on renal function only and it significantly
differs between healthy volunteers and severely ill patients. Herein, we propose a …